The Asia Pacific traumatic brain injury diagnostics equipment market was valued at US$ 362.82 million in 2022 and is expected to reach US$ 1,030.47 million by 2030; it is estimated to register a CAGR of 13.9% from 2022 to 2030.
Although CT is often used in emergency settings for detecting life-threatening head injuries, it can miss subtle findings, such as contusions, small areas of hemorrhage, and diffuse axonal injury. As per the Health Economics Resource Center (HERC) report, the research studies revealed that CT has missed 10–20% of the brain abnormalities that magnetic resonance imaging (MRI) distinctively detects. According to an article published by the Journal of Clinical Imaging Science, the inpatient brain MRI was independently associated with lower mortality. Contrastingly, the use of CT in the evaluation and management of severe TBI is attributable to cancer risk and cancer-related mortality due to radiation exposure. Further, according to the Health Economics Resource Center (HERC) report, the comorbidity-adjusted cost of CT scan was US$ 284 for mild TBI and US$ 455 for severe TBI, standing higher than MRI, which was US$ 230 for mild TBI and US$ 309 for severe TBI cases. In 2018, MRI value per unit cost accounted for US$ 732, with a range of US$ 692 to US$ 750 for TBI based on severity. Therefore, MRI is widely used in TBI diagnosis and management to limit mortality rates and marginally reduce diagnostic costs.
The accelerated demand for advanced diagnostic equipment and quick and effective diagnosis for TBI patients are the key driving factors behind the market development. However, adverse effects of contrast/medium agent is hampering the market growth. Asia Pacific traumatic brain injury diagnostic equipment market covers China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. Asia Pacific traumatic brain injury diagnostic equipment market holds highest CAGR for the market growth for the forecast period 2022-2030. China holds largest market share for traumatic brain injury diagnostic equipment market. However, Japan holds highest CAGR of 14.7% for traumatic brain injury diagnostic equipment market. Launching of innovative products by the Chinese medical device manufacturers is a key factor responsible for market growth for the forecast period.
Strategic insights for the Asia Pacific Traumatic Brain Injury Diagnostics Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Asia Pacific Traumatic Brain Injury Diagnostics Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Asia Pacific Traumatic Brain Injury Diagnostics Equipment Strategic Insights
Asia Pacific Traumatic Brain Injury Diagnostics Equipment Report Scope
Report Attribute
Details
Market size in 2022
US$ 362.82 Million
Market Size by 2030
US$ 1,030.47 Million
Global CAGR (2022 - 2030)
13.9%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Techniques
By Device
By End User
Regions and Countries Covered
Asia Pacific
Market leaders and key company profiles
Asia Pacific Traumatic Brain Injury Diagnostics Equipment Regional Insights
The Asia Pacific traumatic brain injury diagnostics equipment market is categorized into techniques, device, end user, and country.
Based on techniques, the Asia Pacific traumatic brain injury diagnostics equipment market is segmented into non-invasive, invasive, and combination techniques. The invasive segment held the largest Asia Pacific traumatic brain injury diagnostics equipment market share in 2022. Furthermore, the non-invasive segment is subcategorized into electroencephalography (EEG), brain–computer interface (BCI), eye tracking and near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), cerebral metabolic rate of oxygen (CMRO2), intracranial pressure, and others. Additionally, invasive segment is subsegmented into cerebral perfusion pressure (CPP) and pressure reactivity index (PRx), partial brain tissue oxygen pressure (PbtO2), cerebral microdialysis (CMD), intracranial pressure, and others.
In terms of device, the Asia Pacific traumatic brain injury diagnostics equipment market is bifurcated into imaging devices and monitoring devices. The imaging devices segment held a larger Asia Pacific traumatic brain injury diagnostics equipment market share in 2022.
By end user, the Asia Pacific traumatic brain injury diagnostics equipment market is divided into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held the largest Asia Pacific traumatic brain injury diagnostics equipment market share in 2022.
By country, the Asia Pacific traumatic brain injury diagnostics equipment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific traumatic brain injury diagnostics equipment market share in 2022.
GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, Soterix Medical Inc, Medtronic Plc, Compumedics Ltd, and Sense Diagnostics Inc are some of the leading companies operating in the Asia Pacific traumatic brain injury diagnostics equipment market.
The Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market is valued at US$ 362.82 Million in 2022, it is projected to reach US$ 1,030.47 Million by 2030.
As per our report Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market, the market size is valued at US$ 362.82 Million in 2022, projecting it to reach US$ 1,030.47 Million by 2030. This translates to a CAGR of approximately 13.9% during the forecast period.
The Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market report:
The Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market value chain can benefit from the information contained in a comprehensive market report.